Notre Dame: Understudied Cell in the Brain Could Be Key to Treating Glioblastoma
December 13, 2023
December 13, 2023
NOTRE DAME, Indiana, Dec. 13 (TNSres) -- The University of Notre Dame issued the following news:
Glioblastoma is one of the most treatment-resistant cancers, with those diagnosed surviving for less than two years.
In a new study in NPJ Genomic Medicine, researchers at the University of Notre Dame have found that a largely understudied cell could offer new insight into how the aggressive, primary brain cancer is able to resist immunotherapy.
"A decade a . . .
Glioblastoma is one of the most treatment-resistant cancers, with those diagnosed surviving for less than two years.
In a new study in NPJ Genomic Medicine, researchers at the University of Notre Dame have found that a largely understudied cell could offer new insight into how the aggressive, primary brain cancer is able to resist immunotherapy.
"A decade a . . .